Zacks highlights Select Medical (SEM) as a potentially attractive momentum stock, noting its Zacks Rank of #3 (Hold) and a VGM Score of B. SEM's shares are up 2.2% over the past four weeks, with a Momentum Style Score of B and one analyst raising their fiscal 2025 earnings estimate; the Zacks Consensus Estimate has increased to $1.14 per share, reflecting an average earnings surprise of 8.3%.
Select Medical (SEM) is highlighted by Zacks as a healthcare stock with notable momentum characteristics, despite carrying a Zacks Rank of #3 (Hold). The company has achieved a Momentum Style Score of B and its shares have appreciated by 2.2% over the past four weeks. Supporting a potentially positive outlook, one analyst revised their fiscal 2025 earnings estimate higher in the last 60 days; however, the Zacks Consensus Estimate for fiscal 2025 earnings per share has remained unchanged at $1.14. SEM also demonstrates a consistent record of exceeding earnings expectations, with an average earnings surprise of 8.3%. Combined with a VGM Score of B, these factors suggest SEM may offer upside potential, particularly as Zacks methodology indicates that a #3 Rank stock with A or B Style Scores can still be attractive. The general sentiment from the provided signals is strongly positive regarding SEM, though the immediate market impact score is low.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.60
Ticker Sentiment